Table 2 of Guo, Mol Vis 2012; 18:1175-1181.

Table 2. Expression of MMP-2 and MMP-9 among the three POAG patients.

  MMP-2 (mg/ml) by RT–PCR* MMP-2 (mg/ml) by gelatin zymography
  Hyaluronic acid Hyaluronic acid
POAG patients 0 mg/ml 1 mg/ml 3 mg/ml 6 mg/ml 0 mg/ml 1 mg/ml 3 mg/ml 6 mg/ml
Patient 1 0.60 1.13 1.45 1.90 180 270 356 452
Patient 2 0.66 1.13 1.42 1.87 179 265 351 442
Patient 3 0.62 1.08 1.37 1.85 170 259 354 449
Mean 0.63 1.11 1.41 1.87 176 264 353 448
  MMP-9 (mg/ml) by RT–PCR* MMP-9 (mg/ml) by gelatin zymography
  Hyaluronic acid Hyaluronic acid
POAG patients  0 mg/ml 1 mg/ml 3 mg/ml 6 mg/ml 0 mg/ml 1 mg/ml 3 mg/ml 6 mg/ml
Patient 1 0.71 1.06 1.28 2.08 547 653 901 1132
Patient 2 0.62 1.08 1.38 2.05 552 653 887 1153
Patient 3 0.69 1.15 1.40 2.12 541 669 896 1156
Mean 0.67 1.10 1.35 2.08 547 659 895 1147

* Reverse transcription-polymerase chain reaction. MMP=Matrix metalloproteinases; POAG=Primary open-angle glaucoma.

Guo, Mol Vis 2012; 18:1175-1181. http://www.molvis.org/molvis/v18/a123

©2012 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535